News | June 10, 2010

Software Certified for ACC ICD Registry

June 10, 2010 – The American College of Cardiology (ACC) has certified Lumedx Corp. as an official ACC-National Cardiovascular Data Registry (NCDR) Implantable Cardioverter Defibrillator (ICD) Registry 2.0 software vendor.

Lumedx exports to the ICD registry is the latest in a suite of software applications developed to address the growing need for accessible cardiovascular data, streamlined clinical workflows and data management.

As the health care industry places more emphasis on quality measurement, transparency and evidence-based care, registry participation becomes increasingly critical. The ACC-NCDR ICD Registry collects data for implantable cardioverter defibrillator procedures. Version 2.0 has been extended to include pediatric ICD implant data, trial, ventricular, defibrillator, and left-heart lead information at time of implant, revision, replacement or surgical abandonment, and updated quality indicators.

The ICD registry module enables comprehensive data collection while simplifying the registry-participation process. The software is designed to integrate with other Apollo clinical data repository modules so it merges seamlessly with the Lumedx electrophysiology module.

For more information: www.lumedx.com/registry/index.as


Related Content

News | Cardiovascular Clinical Studies

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

Home May 02, 2024
Home
News | Cardiovascular Clinical Studies

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

Home May 01, 2024
Home
News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Subscribe Now